http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2584082-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d660e235914231350650737c0e2a736
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-203
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
filingDate 2015-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec4612a9a335ce259184e83784d38ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c644bfd4385119eaca1b042d8477ac88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e8f50f973910d18997cdd14f26e7a4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe8f573d26b13c7c701c63e950796fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9179641e39cef1eea7f3cd1e337d3bf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d17d34911029217b79a0c75b01a10e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32470abad4ce58c294cfa574d50f6904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15bf198bbd4f86ca93e8da540354acb7
publicationDate 2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2584082-C1
titleOfInvention Method of treating hemangiomas
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, specifically to surgery, and can be used in treatment of hemangiomas. Propranolol is taken in a dose of 1 mg/kg a day in three times. Dose is increased during 3-6 days to 2 mg/kg. After 1-2 weeks 50 % of surface of hemangioma is treated with Nd:YAG laser in a pulsed mode with energy of 120 J/cm 2 . Areas untreated and treated with laser are alternated in a mosaic manner. Laser exposure is performed every 3-4 weeks until disappearance of hemangiomas. Termination of propanol therapy is carried out 3-4 weeks after last session of laser exposure. n EFFECT: method reduces risk of burns and scarring due to action of laser with low power against background of propanol therapy. n 1 cl, 1 ex
priorityDate 2015-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009050567-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2290228-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031

Total number of triples: 27.